{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:46:10Z","timestamp":1782344770447,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:00:00Z","timestamp":1711670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["RYC2021-031346-I"],"award-info":[{"award-number":["RYC2021-031346-I"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["MICIU\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["MICIU\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["963845"],"award-info":[{"award-number":["963845"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["MCIN\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["MCIN\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["PID2021-125573OB-I00"],"award-info":[{"award-number":["PID2021-125573OB-I00"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Espana Ministerio de Ciencia e Innovacion","doi-asserted-by":"publisher","award":["RYC2021-031346-I"],"award-info":[{"award-number":["RYC2021-031346-I"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/00690"],"award-info":[{"award-number":["PI20\/00690"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.biopha.2024.116530","type":"journal-article","created":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T08:38:58Z","timestamp":1712133538000},"page":"116530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Novel clinical phenotypes, drug categorization, and outcome prediction in drug-induced cholestasis: Analysis of a database of 432 patients developed by literature review and machine learning support"],"prefix":"10.1016","volume":"174","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6684-8731","authenticated-orcid":false,"given":"Marta","family":"Moreno-Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"L\u00f3pez-Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6829-4736","authenticated-orcid":false,"given":"Anna","family":"Rapisarda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Quint\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6577-5630","authenticated-orcid":false,"given":"Annika","family":"Drees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1859-0083","authenticated-orcid":false,"given":"Inger-Lise","family":"Steffensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8621-1452","authenticated-orcid":false,"given":"Thomas","family":"Luechtefeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8929-5364","authenticated-orcid":false,"given":"Eva","family":"Serrano-Candelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Garcia","family":"de Lomana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Gadaleta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Dirven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Vinken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4914-5804","authenticated-orcid":false,"given":"Ramiro","family":"Jover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.116530_bib1","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.fct.2018.07.017","article-title":"Advances in drug-induced cholestasis: Clinical perspectives, potential mechanisms and in vitro systems","volume":"120","author":"Fern\u00e1ndez-Murga","year":"2018","journal-title":"Food Chem. Toxicol."},{"issue":"8","key":"10.1016\/j.biopha.2024.116530_bib2","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.cgh.2022.12.040","article-title":"The Evolving Profile of Idiosyncratic Drug-Induced Liver Injury","volume":"21","author":"Fontana","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116530_bib3","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3390\/metabo12060564","article-title":"The potential role of metabolomics in drug-induced liver injury (DILI) assessment","volume":"12","author":"Moreno-Torres","year":"2022","journal-title":"Metabolites"},{"issue":"8","key":"10.1016\/j.biopha.2024.116530_bib4","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/lt.20204","article-title":"Liver transplantation for acute liver failure from drug induced liver injury in the United States","volume":"10","author":"Russo","year":"2004","journal-title":"Liver Transpl."},{"issue":"9","key":"10.1016\/j.biopha.2024.116530_bib5","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1080\/00365520510023846","article-title":"Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden","volume":"40","author":"Bj\u00f6rnsson","year":"2005","journal-title":"Scand. J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.biopha.2024.116530_bib6","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep4.1088","article-title":"Drug-induced cholestasis","volume":"1","author":"Sundaram","year":"2017","journal-title":"Hepatol. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2024.116530_bib7","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0168-8278(90)90124-A","article-title":"Criteria of drug-induced liver disorders. Report of an international consensus meeting","volume":"11","author":"B\u00e9nichou","year":"1990","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116530_bib8","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0025-7125(16)30638-1","article-title":"Drug-induced liver disease","volume":"73","author":"Lewis","year":"1989","journal-title":"Med Clin. North Am."},{"issue":"1","key":"10.1016\/j.biopha.2024.116530_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1089-3261(05)70097-0","article-title":"Drug-induced liver disease","volume":"4","author":"Zimmerman","year":"2000","journal-title":"Clin. Liver Dis."},{"issue":"2","key":"10.1016\/j.biopha.2024.116530_bib10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cld.2012.11.002","article-title":"Drug-induced cholestasis","volume":"17","author":"Bjornsson","year":"2013","journal-title":"Clin. Liver Dis."},{"issue":"4","key":"10.1016\/j.biopha.2024.116530_bib11","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/hep.24229","article-title":"Drug-induced cholestasis","volume":"53","author":"Padda","year":"2011","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.biopha.2024.116530_bib12","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/hep.21424","article-title":"Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry","volume":"44","author":"Andrade","year":"2006","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.biopha.2024.116530_bib13","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2013.02.006","article-title":"Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland","volume":"144","author":"Bj\u00f6rnsson","year":"2013","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.biopha.2024.116530_bib14","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/hep.26208","article-title":"High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury","volume":"58","author":"Chen","year":"2013","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.biopha.2024.116530_bib15","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/hep.28678","article-title":"A Model to predict severity of drug-induced liver injury in humans","volume":"64","author":"Chen","year":"2016","journal-title":"Hepatology"},{"issue":"19","key":"10.1016\/j.biopha.2024.116530_bib16","doi-asserted-by":"crossref","first-page":"17031","DOI":"10.18632\/oncotarget.4400","article-title":"A comprehensive study of the association between drug hepatotoxicity and daily dose, liver metabolism, and lipophilicity using 975 oral medications","volume":"6","author":"Weng","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2024.116530_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/frai.2021.685298","article-title":"Sysrev: A FAIR Platform for Data Curation and Systematic Evidence Review","volume":"4","author":"Bozada","year":"2021","journal-title":"Front Artif. Intell."},{"issue":"6","key":"10.1016\/j.biopha.2024.116530_bib18","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/clpt.2011.58","article-title":"Case Definition and Phenotype Standardization in Drug-Induced Liver Injury","volume":"89","author":"Aithal","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.biopha.2024.116530_bib19","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.03.006","article-title":"Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study","volume":"148","author":"Chalasani","year":"2015","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.biopha.2024.116530_bib20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jhep.2021.08.024","article-title":"Infliximab-induced liver injury: Clinical phenotypes, autoimmunity and the role of corticosteroid treatment","volume":"76","author":"Bj\u00f6rnsson","year":"2022","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116530_bib21","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.gastro.2005.05.006","article-title":"Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period","volume":"129","author":"Andrade","year":"2005","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.biopha.2024.116530_bib22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jhep.2021.01.029","article-title":"Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry","volume":"75","author":"Stephens","year":"2021","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116530_bib23","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hep.20800","article-title":"Outcome and prognostic markers in severe drug-induced liver disease","volume":"42","author":"Bj\u00f6rnsson","year":"2005","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.biopha.2024.116530_bib24","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jhep.2016.05.003","article-title":"Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury","volume":"65","author":"Medina-Caliz","year":"2016","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116530_bib25","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.26709","article-title":"Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations","volume":"59","author":"Kleiner","year":"2014","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.biopha.2024.116530_bib26","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1111\/j.1365-2036.2007.03330.x","article-title":"The impact of eosinophilia and hepatic necrosis on prognosis in patients with drug-induced liver injury","volume":"25","author":"Bj\u00f6rnsson","year":"2007","journal-title":"Aliment Pharm. Ther."},{"issue":"4","key":"10.1016\/j.biopha.2024.116530_bib27","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/hep.28967","article-title":"Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements","volume":"65","author":"Bonkovsky","year":"2017","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.biopha.2024.116530_bib28","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/ajg.2010.216","article-title":"Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis","volume":"105","author":"Kumagi","year":"2010","journal-title":"Am. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116530_bib29","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1089-3261(05)70023-4","article-title":"DRUG-INDUCED CHOLESTASIS: Pathobiology and clinical features","volume":"2","author":"Simon","year":"1998","journal-title":"Clin. Liver Dis."},{"issue":"1","key":"10.1016\/j.biopha.2024.116530_bib30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1208\/s12248-013-9541-z","article-title":"Estimation of biliary excretion of foreign compounds using properties of molecular structure","volume":"16","author":"Sharifi","year":"2014","journal-title":"AAPS J."},{"issue":"4","key":"10.1016\/j.biopha.2024.116530_bib31","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1124\/dmd.113.056267","article-title":"High daily dose and being a substrate of cytochrome P450 enzymes are two important predictors of drug-induced liver injury","volume":"42","author":"Yu","year":"2014","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.biopha.2024.116530_bib32","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/hep.23317","article-title":"Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events","volume":"51","author":"Lammert","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biopha.2024.116530_bib33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1053\/j.gastro.2014.03.050","article-title":"Use of Hy\u2019s law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury","volume":"147","author":"Robles-Diaz","year":"2014","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.biopha.2024.116530_bib34","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/hep.22895","article-title":"Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex","volume":"49","author":"Lucena","year":"2009","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.biopha.2024.116530_bib35","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S2468-1253(20)30006-6","article-title":"Drug-induced liver injury in older people","volume":"5","author":"Lucena","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116530_bib36","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/pds.1211","article-title":"Hy\u2019s law: predicting serious hepatotoxicity","volume":"15","author":"Temple","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"13","key":"10.1016\/j.biopha.2024.116530_bib37","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.cgh.2015.06.020","article-title":"Risk of acute liver failure in patients with drug-induced liver injury: evaluation of Hy\u2019s law and a new prognostic model","volume":"13","author":"Lo Re","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116530_bib38","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/hep.29283","article-title":"Death and liver transplantation within 2 years of onset of drug-induced liver injury","volume":"66","author":"Hayashi","year":"2017","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.biopha.2024.116530_bib39","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/hep.29802","article-title":"Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: an international collaborative effort","volume":"69","author":"Church","year":"2019","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.biopha.2024.116530_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.cld.2013.07.015","article-title":"Drug-induced cholestasis","volume":"17","author":"Bhamidimarri","year":"2013","journal-title":"Clin. Liver Dis."},{"issue":"4","key":"10.1016\/j.biopha.2024.116530_bib41","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.drudis.2016.02.015","article-title":"DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans","volume":"21","author":"Chen","year":"2016","journal-title":"Drug Discov. Today"},{"issue":"9","key":"10.1016\/j.biopha.2024.116530_bib42","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.cgh.2017.12.051","article-title":"Herbal and dietary supplement-induced liver injuries in the Spanish DILI registry","volume":"16","author":"Medina-Caliz","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol."}],"updated-by":[{"DOI":"10.1016\/j.biopha.2024.116813","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000}}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224004141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224004141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T22:47:07Z","timestamp":1782341227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224004141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":42,"alternative-id":["S0753332224004141"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116530","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel clinical phenotypes, drug categorization, and outcome prediction in drug-induced cholestasis: Analysis of a database of 432 patients developed by literature review and machine learning support","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116530","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116530"}}